Science ❯ Medicine ❯ Pharmacology

Drug Development

Targeted Protein Degradation Technologies Exercise Mimicking Pills Clinical Research Seizure Medications Drug Screening CXCR4 Inhibitors BCR::ABL1 Inhibitors Clinical Studies Precision Medicine

Mount Sinai's V2P AI Predicts Disease Type From Genetic Mutations

The Nature Communications study reports improved variant ranking in patient tests.

Terns’ TERN-701 Shows Strong CML Responses in CARDINAL, Setting 320 mg and 500 mg Phase 2 Doses

Exicure’s Burixafor Delivers About 90% Stem-Cell Mobilization in Phase 2 as Shares Surge

Bayer Stroke Drug Asundexian Hits Phase III Goals, Shares Jump

Cambridge Scientists Grow Self-Organising ‘Hematoids’ That Produce Human Blood Stem Cells